Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs - Image 1

£83.58

Hart Publishing Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Name: Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs
Brand: Hart Publishing
Price: 83.58 GBP
Availability: InStock

Law

This is the most expensive it has ever been. Walk away.

£84 today · previous high £84 · all-time low £40

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 603 days • 603 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 603 days • 5 price levels

Days at Price

Current Price

Price Analysis

Most common price: £80 (530 days, 87.9%)

Price range: £40 - £83

Price levels: 5 different prices over 603 days

Description

This book analyses 4 central pieces of EU pharmaceutical regulation: the Orphan Drugs Regulation, the Paediatric Regulation, the Supplementary Protection Certificate Regulation, and the ATMP (Advanced Therapy Medicinal Products) Regulation. These four regulatory instruments constitute focal points in the pharmaceutical industry’s approach to modern business and legal strategy. Their central role is justified by the way these regulatory instruments interact with each other and with the patent system, and by the considerable impact they (as a whole) have for the evergreening of exclusive rights on pharmaceutical products. The book guides the reader through the latest case law and legislative developments and discusses how these influence strategic legal and business choices in the pharmaceutical industry. It brings to the forefront the often-overlooked significance of the legislative architecture of the EU pharmaceutical regulatory framework, and evaluates its results through the lens of the efficiency test. The book is an important resource for academics and practitioners interested in updated case law and an in-depth analysis of these four regulations. It is also important for those interested in legislative studies, evaluation of legislation and a critical approach to legislative architecture.

Product Specifications

Brand: Hart Publishing
Format: hardcover
ASIN: 1509950281
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 21 October 2021
Listed Since: 08 February 2021

Barcode

No barcode data available

Hart Publishing Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health, and Pharmaceuticals (Law, Development and Globalization)

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Patent Rights in Pharmaceuticals in Developing Countries: Major Challenges for the Future

Patent Protection for Second Medical Uses (Aippi Law)

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective

Drugs, Patents and Policy: A Contextual Study of Hong Kong

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Guide to EU Pharmaceutical Regulatory Law

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health? (Palgrave Studies in Public Health Policy Research)

Regional Cooperation, Intellectual Property Law and Access to Medicines: A Holistic Approach for Least Developed Countries (Routledge Research in Health Law)

Guide to EU and UK Pharmaceutical Regulatory Law

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Oxford University Press - Balancing Wealth and Health Book

Intellectual Property and Health Technologies: Balancing Innovation and the Public's Health

World Pharmaceutical Industry

Intellectual Property in the Life Sciences: A Global Guide to Rights and Their Applications, Second Edition

Pharmaceutical Medicine (Oxford Specialist Handbooks)

EU Law of Competition and Trade in the Pharmaceutical Sector (Elgar Competition Law and Practice series)

The Law of Off-label Uses of Medicines: Regulation and Litigation in the EU, UK and USA

International Pharmaceutical Product Registration: 200 (Drugs and the Pharmaceutical Sciences)

Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry

Pharmaceutical Product Development: Insights Into Pharmaceutical Processes, Management and Regulatory Affairs